NMN vs NR: Which NAD+ Precursor Should You Take?

The longevity supplement market has exploded around NAD+ precursors, with NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) competing for dominance. After analyzing the biochemistry, reviewing every human clinical trial through early 2025, and calculating price per effective dose, here is a clear-eyed comparison free from the hype surrounding either compound.

The NAD+ Pathway Explained

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell, essential for energy metabolism, DNA repair, sirtuin activation, and cellular signaling. NAD+ levels decline approximately 50% between ages 40 and 60, according to Massudi et al. (2012). This decline is associated with mitochondrial dysfunction, impaired DNA repair, and the hallmarks of aging.

Both NMN and NR are precursors to NAD+, meaning the body converts them into NAD+ through enzymatic pathways. NR is converted to NMN by nicotinamide riboside kinases (NRK1 and NRK2), and NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases (NMNATs). Critically, NR must first become NMN before becoming NAD+. This is the core of the debate: is it better to supplement NMN directly, skipping one enzymatic step, or does NR have advantages that offset this extra conversion?

The Case for NMN

NMN is one step closer to NAD+ in the biosynthetic pathway. The SNAC transporter (Slc12a8), identified by Grozio et al. (2019), enables direct NMN transport into cells without prior conversion to NR. This discovery challenged the earlier assumption that NMN was too large to enter cells intact and had to be broken down to NR first.

Key human studies include: Yi et al. (2023) demonstrated that 600mg NMN daily for 60 days increased NAD+ levels by approximately 38% in healthy adults. Liao et al. (2021) showed that 250mg NMN daily improved muscle insulin sensitivity in postmenopausal prediabetic women. Igarashi et al. (2022) found that 250mg NMN daily improved lower limb function and reduced drowsiness in older men over 12 weeks.

David Sinclair, the Harvard geneticist who popularized NMN, has publicly stated he takes 1,000mg NMN daily (sublingual) along with resveratrol and metformin. While his personal protocol is not a clinical study, his lab's research on NMN's effects on NAD+ metabolism and sirtuin activation has been foundational (Mills et al., 2016).

Sublingual vs. capsule: Sublingual NMN bypasses first-pass liver metabolism, potentially delivering more intact NMN to systemic circulation. However, no head-to-head clinical trial has directly compared sublingual vs. oral NMN absorption in humans. The theoretical advantage is plausible based on pharmacokinetic principles but remains unproven at the clinical level.

The Case for NR

Nicotinamide riboside has a longer track record in human clinical trials. Martens et al. (2018) demonstrated that 1,000mg NR daily (as Niagen) for 6 weeks increased NAD+ levels by approximately 60% in healthy older adults, with no adverse effects. This is a larger increase than most NMN studies have shown, though direct comparison is complicated by different study designs.

NR also has a key advantage: it is an approved New Dietary Ingredient (NDI) with the FDA, while NMN's regulatory status was briefly contested in 2022-2023 before being resolved. Tru Niagen (ChromaDex) holds the patent on NR as Niagen and has invested heavily in clinical research, with over 35 published studies using their ingredient.

Conze et al. (2019) conducted a comprehensive safety study showing NR at 1,000mg/day for 8 weeks was well-tolerated with no liver or kidney toxicity. Dollerup et al. (2018) found that 2,000mg NR daily improved body composition and sleeping metabolic rate in obese men, though cognitive outcomes were not measured.

Price Per Effective Dose

Our Verdict

For most people, sublingual NMN at 500mg/day (e.g. ProHealth NMN Pro) offers the best combination of efficacy, value, and theoretical advantage. It skips an enzymatic step compared to NR, uses a delivery method that may enhance bioavailability, and costs less per milligram than most NR options. For those who prefer the more extensive clinical evidence base and regulatory certainty, Tru Niagen at 300mg/day is the safer, more conservative choice.

Contrarian take: The entire NAD+ precursor category may be solving a problem that better matches simpler interventions. Regular exercise increases NAD+ levels by 50-127% depending on intensity (Lamb et al., 2020). Niacin (vitamin B3), at $5/month, also raises NAD+ levels effectively, though with flushing side effects. Before spending $40-60/month on NMN or NR, ensure you are exercising regularly and have optimized foundational health markers. NAD+ precursors are a finishing touch, not a replacement for the fundamentals covered in our beginner's biohacking guide.

Disclaimer: This article is for informational purposes only and is not medical advice. Statements about supplements have not been evaluated by the Food and Drug Administration, and nothing here is intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any supplement, device, or protocol.